← Eichor
Condition: Tuberculous Meningitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tuberculous Meningitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Adjunctive Doxycycline for Central Nervous System Tuberculosis
Phase 2 · 6 location(s) · National University Hospital, Singapore · NCT06446245
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
Phase 3 · 13 location(s) · ANRS, Emerging Infectious Diseases · NCT04145258
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard
Phase 2 · 18 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05383742
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Phase 2 · 3 location(s) · ANRS, Emerging Infectious Diseases · NCT05590455
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.